The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery

被引:3
|
作者
Tasbulak, Omer [1 ]
Sahin, Anil [1 ]
机构
[1] Univ Hlth Sci, Mehmet Akif Ersoy Thorac & Cardiovasc Surg Traini, Cardiol, Istanbul, Turkey
关键词
graft; graft failure; graft patency; coronary artery bypass surgery; cha2ds2-vasc; IN-HOSPITAL MORTALITY; SAPHENOUS-VEIN; DISEASE; ATHEROSCLEROSIS; VALIDATION; BURDEN; STROKE;
D O I
10.7759/cureus.22833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective Graft patency is one of the major concerns after coronary artery bypass graft (CABG) surgery. The CHA(2)DS(2)-VASc [congestive heart failure, hypertension, age >= 75 years, diabetes mellitus (DM), stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category] score is a tool that was developed to predict the risk of thrombotic events in patients with atrial fibrillation (AF). In this study, we evaluated the use of the CHA(2)DS(2)-VASc score as a simple tool for predicting graft failure (GF) among patients who underwent CABG surgery. Methods In this retrospective case-control study, a total of 280 patients were enrolled after applying the exclusion criteria. Angiograms were analyzed by using the QCA software system (Pie Medical Imaging, Maastricht, The Netherlands) for each patient. A graft was described as failed if it had 70% or more stenosis or was completely occluded. Patients were classified into two groups: group one included patients without GF (GF-N) and group two included patients with GF (GF-Y). Thereafter, the CHA(2)DS(2)-VASc risk score was calculated for each patient. Results In our cohort, 136 patients had GF (GF-Y group) and 144 patients did not have GF (GF-N group). GF-N and GF-Y patients had their angiography performed 100.31 +/- 8.04 and 103.49 +/- 8.41 months after CABG, respectively. GF-Y group had a significantly higher rate of DM, hypertension, and heart failure with reduced ejection fraction (HFrEF). GF-Y group had higher CHA(2)DS(2) (GF-N group: 1.47 +/- 0.91 vs. GF-Y group: 2.57 +/- 1.17, p=0.0001) and CHA(2)DS(2)-VASc score (GF-N group: 2.80 +/- 1.11 vs. GE-Y group: 4.15 +/- 1.25, p=0.0001). Analyses showed that only CHA(2)DS(2)-VASc was an independent predictor of GF while other parameters including DM, hypertension, HFrEF, creatinine, and CHADS(2) were not found to be independent predictors of GE. A CHA(2)DS(2)-VASc score of >3 predicted GF with a sensitivity of 65.44% and a specificity of 74.31%. Conclusions The CHA(2)DS(2)-VASc score might be used as a feasible and simple method to predict the risk of GF after CABG surgery.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
    Zheng, Jian-Yong
    Li, Dong-Tao
    Qiu, Yi-Gang
    Huang, Yi-Xiong
    Xu, Zheng-Ming
    Zhao, Li
    Chen, Yu
    Cao, Yi
    Tang, Yi-Da
    Guo, Cheng-Jun
    Ma, Zhi-Min
    Wu, Yong-Quan
    Jiao, Yan
    Li, Tian-Chang
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 1103 - 1110
  • [42] CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion
    Falsetti, Lorenzo
    Viticchi, Giovanna
    Tarquinio, Nicola
    Silvestrini, Mauro
    Capeci, William
    Balloni, Andrea
    Catozzo, Vania
    Gentile, Adelina
    Pellegrini, Francesco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2014, 15 (08) : 636 - 641
  • [43] Analysis of the CHA2DS2-VASc score in patients with inadequate anticoagulation control
    Almeida Campos, Laura Raiane
    Fernandes, Ludmila Albino
    de Souza, Igor Goncalves
    Malta, Jessica Soares
    da Costa, Josiane Moreira
    Parreiras Martins, Maria Auxiliadora
    MUNDO DA SAUDE, 2021, 45 (01): : 318 - 326
  • [44] CHA2DS2-VASc score is no longer enough-Authors' reply
    Noubiap, Jean Jacques
    Middeldorp, Melissa E.
    Thomas, Gijo
    Sanders, Prashanthan
    EUROPACE, 2022,
  • [45] CHA2DS2-VASc score and prognosis in ischemic strokes with atrial fibrillation
    Eva Giralt-Steinhauer
    Elisa Cuadrado-Godia
    Ángel Ois
    Jordi Jiménez-Conde
    Ana Rodríguez-Campello
    Lluis Planellas
    Sara Jimena-García
    Miguel Ángel Rubio
    Jaume Roquer-González
    Journal of Neurology, 2012, 259 : 745 - 751
  • [46] Predicting stroke and death in patients with heart failure using CHA2DS2-VASc score in Asia
    Son, Mi Kyoung
    Lim, Nam-Kyoo
    Park, Hyun-Young
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (01):
  • [47] Use of CHADS2 and CHA2DS2-VASc scores to predict prognosis after stroke
    Vitturi, B. Kusznir
    Gagliardi, R. Jose
    REVUE NEUROLOGIQUE, 2020, 176 (1-2) : 85 - 91
  • [48] Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
    Pooja S. Jagadish
    Rajesh Kabra
    Current Cardiology Reports, 2019, 21
  • [49] The association between CHA2DS2-VASc score and aortic valve sclerosis
    Basyigit, Funda
    Gursoy, Havva Tugba
    Celebi, Ozlem Ozcan
    Balci, Kevser Gulcihan
    Elalmis, Ozgul Ucar
    Ozbek, Kerem
    Karaaslan, Ozge Cakmak
    Ileri, Mehmet
    Keles, Telat
    Aydogdu, Sinan
    CARDIOVASCULAR JOURNAL OF AFRICA, 2023, : 134 - 139
  • [50] Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation
    Mason, Pamela K.
    Lake, Douglas E.
    DiMarco, John P.
    Ferguson, John D.
    Mangrum, J. Michael
    Bilchick, Kenneth
    Moorman, Liza P.
    Moorman, J. Randall
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (06) : 603.e1 - 603.e6